CEFOTAXIME INJECTION cefotaxime 2g (as sodium) powder for injection vial

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

cefotaxime sodium, Quantity: 2097 mg (Equivalent: cefotaxime, Qty 2000 mg)

Dostupné s:

Lupin Australia Pty Limited

Léková forma:

Injection, powder for

Složení:

Excipient Ingredients:

Podání:

Intravenous

Terapeutické indikace:

Cefotaxime Injection is indicated for the treatment of the following types of infection when caused by susceptible micro-organisms. Infections of the respiratory tract (upper and lower). Infections of the urinary tract. Septicaemia - concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. Intra-abdominal infection. Gonorrhoea (including gonorrhoea caused by beta-lactamase producing strains of N. gonorrhoeae.) Ear, nose and throat (ENT) infections. Skin and skin structure infections. Bone and joint infections. Meningitis - Cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or penicillin G) for initial therapy in children, (excluding neonates), pending the availability of culture and sensitivity results. In adults the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by gram-negative enteric bacilli. Cefotaxime Injection may be used for the prevention of post-operative infection in obstetric surgery, vaginal and abdominal hysterectomy and biliary surgery. In serious cases, Cefotaxime Injection may be used, if considered appropriate, before the results of sensitivity tests become available. The emergence of resistance to cefotaxime may complicate treatment.

Přehled produktů:

Visual Identification: Clear glass vial containing a white to slightly yellow powder.;

Stav Autorizace:

Registered

Datum autorizace:

2004-07-27